Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cold exposure and metabolic health: Therapeutic potential for obesity, diabetes, and beyond.

Physiological reports·2026
Same author

Parkinson's associated protein DJ-1 regulates intercellular communication via extracellular vesicles in oxidative stress.

Cell death discovery·2025
Same author

Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologies.

NPJ digital medicine·2025
Same author

Disrupted adipokine secretion and inflammatory responses in human adipocyte hypertrophy.

Adipocyte·2025
Same author

Development of a Sun Protection Factor for contact lenses (CL-SPF).

BMJ open ophthalmology·2025
Same author

Human-based complex <i>in vitro</i> models: their promise and potential for rare disease therapeutics.

Frontiers in cell and developmental biology·2025

Related Experiment Video

Updated: Apr 19, 2026

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

4.9K

Developing accurate models of the human airways.

Lindsay J Marshall1, Wilson Oguejiofor, Rachel S Willetts

  • 1School of Life and Health Sciences, Aston University, Birmingham, UK.

The Journal of Pharmacy and Pharmacology
|January 6, 2015
PubMed
Summary

Developing advanced in vitro models of human airways is crucial for testing inhaled therapeutics and vaccines. These realistic models improve drug delivery research while supporting ethical animal testing guidelines.

Keywords:
cellular drug uptake and absorptiondrug delivery to specific tissues

More Related Videos

A Microfluidic Model of Biomimetically Breathing Pulmonary Acinar Airways
09:39

A Microfluidic Model of Biomimetically Breathing Pulmonary Acinar Airways

Published on: May 9, 2016

8.4K
Establishing Human Lung Organoids and Proximal Differentiation to Generate Mature Airway Organoids
10:12

Establishing Human Lung Organoids and Proximal Differentiation to Generate Mature Airway Organoids

Published on: March 23, 2022

10.3K

Related Experiment Videos

Last Updated: Apr 19, 2026

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

4.9K
A Microfluidic Model of Biomimetically Breathing Pulmonary Acinar Airways
09:39

A Microfluidic Model of Biomimetically Breathing Pulmonary Acinar Airways

Published on: May 9, 2016

8.4K
Establishing Human Lung Organoids and Proximal Differentiation to Generate Mature Airway Organoids
10:12

Establishing Human Lung Organoids and Proximal Differentiation to Generate Mature Airway Organoids

Published on: March 23, 2022

10.3K

Area of Science:

  • Biomedical Engineering
  • Respiratory Medicine
  • Drug Delivery Systems

Background:

  • Inhaled particle delivery offers a targeted, non-invasive route for therapeutics, including vaccines.
  • Current advanced testing necessitates animal models, highlighting the need for ethical alternatives like in vitro models.
  • Realistic in vitro models are essential for initial screening of pulmonary drug delivery systems.

Purpose of the Study:

  • To develop and validate a multi-cellular in vitro model of the human airways.
  • To create a testing platform that mimics airway conditions for pulmonary drug delivery research.
  • To support the ethical framework of the 3Rs (Replacement, Reduction, and Refinement) in preclinical testing.

Main Methods:

  • Design and characterization of a multi-cellular human airway model.
  • Incorporation of key airway features such as epithelial barrier and mucus secretion.
  • Validation of the model's ability to simulate physiological conditions for particle delivery.

Main Results:

  • A multi-cellular human airway model was successfully designed and characterized.
  • The model accurately recapitulates critical airway features, including epithelial barrier function and mucus secretion.
  • The developed model effectively simulates physiological challenges for inhaled particle delivery.

Conclusions:

  • The human pulmonary models effectively recreate barriers to particle delivery in the airways.
  • These models serve as a valid platform for screening novel therapeutic compounds and delivery systems.
  • This research advances in vitro testing methodologies for inhaled therapeutics, aligning with ethical research practices.